Makers Laboratories' Q4 FY 2025-26 Quarterly Results

Result Summary

• Makers Laboratories Ltd reported a 1.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 7.3%.
• Its expenses for the quarter were down by 3.2% QoQ and 0.4% YoY.
• The net profit increased 56.8% QoQ and increased 125.3% YoY.
• The earnings per share (EPS) of Makers Laboratories Ltd stood at 1.85 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Makers Laboratories Ltd is a company that operates primarily within the pharmaceutical industry. The company is involved in the production and distribution of various pharmaceutical products. While specific details regarding the company's main products and any recent major developments are not available in the provided data, Makers Laboratories Ltd is likely engaged in the manufacture and supply of medicines and health-related products. The pharmaceutical industry is generally characterized by research and development activities, stringent regulatory environments, and a focus on innovation to address health concerns.

Revenue

During Q4FY26, Makers Laboratories Ltd reported a total income of ₹36.51 crores. This marks a 1.4% increase from the previous quarter (Q3FY26), where the total income was ₹35.99 crores. When compared to the same quarter in the previous year (Q4FY25), the total income showed a more substantial year-over-year increase of 7.3%, up from ₹34.02 crores. These figures suggest a positive trajectory in revenue generation over both short-term and annual periods, reflecting the company’s ability to sustain and grow its income streams.

Profitability

The financial data for Q4FY26 shows that Makers Laboratories Ltd achieved a profit before tax of ₹4.73 crores, representing a significant quarter-over-quarter increase of 50.2% from ₹3.15 crores in Q3FY26. The year-over-year growth was even more pronounced, with an increase of 124.2% from ₹2.11 crores in Q4FY25. After accounting for taxes, the profit after tax for Q4FY26 was ₹3.56 crores, up 56.8% from the previous quarter and 125.3% from the same period last year. The company’s earnings per share (EPS) also reflected substantial growth, standing at ₹1.85 in Q4FY26, compared to ₹1.59 in Q3FY26 and ₹0.08 in Q4FY25.

Operating Metrics

In terms of expenses, Makers Laboratories Ltd reported total expenses of ₹31.78 crores in Q4FY26, which shows a decrease of 3.2% from ₹32.84 crores in the previous quarter. When compared to Q4FY25, where expenses were ₹31.90 crores, there was a slight year-over-year decrease of 0.4%. The tax expense for Q4FY26 was ₹1.17 crores, reflecting increases of 33.0% quarter-over-quarter and 120.8% year-over-year. These operating metrics indicate changes in the company's cost management and tax liabilities over the analyzed periods.